1058 Results for "

peripheral

" in MedChemExpress (MCE) Product Catalog:
Products (1058)

1058 Results for "peripheral" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-P1071A
Synonyms: Calcitonin gene-related peptide TFA
Target:  

CGRP Receptor

Research Areas:  

Cardiovascular Disease

α-CGRP (human) (TFA) is a regulatory neuropeptide of 37 amino acids. α-CGRP (human) (TFA) is widely distributed in the central and peripheral nervous system. α-CGRP (human) (TFA) is a potent vasodilator and has inotropic and chronotropic effects .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P1071
CAS No.: 90954-53-3
Synonyms: Calcitonin gene-related peptide
Target:  

CGRP Receptor

Research Areas:  

Cardiovascular Disease

α-CGRP (human) (Calcitonin gene-related peptide) is a regulatory neuropeptide of 37 amino acids. α-CGRP (human) is widely distributed in the central and peripheral nervous system. α-CGRP (human) is a potent vasodilator and has inotropic and chronotropic effects .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B1337
CAS No.: 67-48-1
Choline chloride is an orally active methylxanthine derivative. Choline chloride exhibits weak antihistaminic and anticholinergic activities and potentiates the effects of histamine and acetylcholine. Choline chloride relaxes bronchial smooth muscle, dilates coronary and peripheral blood vessels, increases urine output and electrolyte excretion, stimulates locomotor activity in the central nervous system, and induces transient hypotension following a pressor phase. Choline chloride modulates sleep architecture by increasing wakefulness time and reducing slow-wave sleep, without altering the frequency or severity of nocturnal hypoxemia, apnea, or hypopnea events. Choline chloride is used in studies of bronchospasm, nocturnal asthma, and chronic asthma .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B1718
CAS No.: 4499-40-5
Synonyms: Oxtriphylline
Choline theophyllinate (Oxtriphylline) is an orally active methylxanthine derivative. Choline theophyllinate exhibits weak antihistaminic and anticholinergic activities and potentiates the effects of histamine and acetylcholine. Choline theophyllinate relaxes bronchial smooth muscle, dilates coronary and peripheral blood vessels, increases urine output and electrolyte excretion, stimulates locomotor activity in the central nervous system, and induces transient hypotension following a pressor phase. It modulates sleep architecture by increasing wakefulness time and reducing slow-wave sleep, without altering the frequency or severity of nocturnal hypoxemia, apnea, or hypopnea events. Choline theophyllinate is used in studies of bronchospasm, nocturnal asthma, and chronic asthma .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-101036
CAS No.: 87-67-2
Purity:  ≥98.0%
Choline bitartrate (Oxtriphylline) is an orally active methylxanthine-derived choline salt of theophylline. Choline bitartrate exhibits weak antihistaminic and anticholinergic activities and can enhance the effects of histamine and acetylcholine. Choline bitartrate relaxes bronchial smooth muscle, dilates coronary and peripheral blood vessels, increases urine output and electrolyte excretion, stimulates central nervous system motor activity, and induces transient hypotension following a pressor phase. Choline bitartrate modulates sleep architecture by increasing wakefulness time and reducing slow-wave sleep, without altering the frequency or severity of nocturnal hypoxemia, apnea, or hypopnea events. Choline bitartrate is used in studies of bronchospasm, nocturnal asthma, and chronic asthma .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-19976
CAS No.: 1024448-59-6
Target:  

TRP Channel

RN-1747 is a selective TRPV4 channel agonist, with EC50 values of 0.77 μM, 4.0 μM and 4.1 μM for hTRPV4, mTRPV4 and rTRPV4, respectively. RN-1747 acts as an antagonist of TRPM8, with an IC50 of 4 μM. Topical cutaneous administration of RN-1747 induces hypothermia, increases tail heat loss via cutaneous vasodilation, and promotes cold-seeking behavior in rats. Intracerebroventricular administration of RN-1747 does not induce hypothermia in rats .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-109108
CAS No.: 1809336-39-7
Purity:  99.68%
Synonyms: DS-3201
Research Areas:  

Cancer

Valemetostat (DS-3201), a first-in-class EZH1/2 dual inhibitor with IC50 values <10 nM. Valemetostat can be used for the research of relapsed/refractory peripheral T-cell lymphoma .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-109108A
CAS No.: 1809336-93-3
Purity:  99.84%
Synonyms: DS-3201 tosylate
Research Areas:  

Cancer

Valemetostat (DS-3201) tosylate, a first-in-class EZH1/2 dual inhibitor with IC50 values <10 nM. Valemetostat tosylate can be used for the research of relapsed/refractory peripheral T-cell lymphoma .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P99168
CAS No.: 1326232-46-5
Synonyms: MDX-1333; MEDI-546
Target:  

IFNAR

Research Areas:  

Inflammation/Immunology

Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-15322
CAS No.: 1370261-96-3
Purity:  99.38%
Synonyms: P505-15; PRT-2607; BIIB-057
Target:  

Syk Apoptosis Caspase

Research Areas:  

Inflammation/Immunology Cancer

PRT062607 (P505-15; PRT-2607) is an orally active ATP-competitive Syk inhibitor with an IC50 value of 1 nM, and exhibits at least 80-fold selectivity over other kinases. PRT062607 blocks B cell antigen receptor-mediated activation, Fcε receptor 1-mediated basophil degranulation and microglial phagocytosis, and induces caspase-dependent apoptosis and microglial death. PRT062607 inhibits tumor growth and peripheral nerve injury-induced mechanical allodynia, and prevents neuronal loss. PRT062607 can be used in research related to rheumatoid arthritis, chronic lymphocytic leukemia, non-Hodgkin's lymphoma, neurodegenerative diseases and neuropathic pain .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-19721
CAS No.: 1235560-28-7
Target:  

Calcium Channel

Research Areas:  

Neurological Disease

ABT-639 is a novel, peripherally acting, selective T-type Ca 2+ channel blocker.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-B0424
CAS No.: 39562-70-4
Synonyms: BAY-E-5009
Nitrendipine (BAY-E-5009) is an orally active analog of Nifedipine (HY-B0284) and dihydropyridine calcium channel blocker. Nitrendipine induces Apoptosis. Nitrendipine has antihypertensive effects. Nitrendipine blocks alcohol and Morphine withdrawal symptoms. Nitrendipine reduces right ventricular hypertrophy and pulmonary vascular changes induced by intermittent hypoxia. Nitrendipine has anticancer effects on neuroblastoma .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13106
CAS No.: 1316755-16-4
Purity:  98.89%
Synonyms: EMA401; PD-126055; (S)-EMA400
Olodanrigan (EMA401) is a highly selective, orally active, peripherally restricted angiotensin II type 2 receptor (AT2R) antagonist. It is under development as a neuropathic pain therapeutic agent. Olodanrigan (EMA401) analgesic action appears to involve inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-149004
CAS No.: 2763730-97-6
Purity:  98.02%
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

SLF1081851 is a Spns2 inhibitor, inhibits S1P release (IC50=1.93 μM). SLF1081851 plays a key role in development and immune system .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-Y0850
CAS No.: 9002-89-5
Research Areas:  

Neurological Disease

Polyvinyl alcohol (Mw 146000-186000, 99+% hydrolyzed) is a non-biodegradable, hydrophilic, odorless biomedical polymer with cell adhesion/proliferation inhibition, peripheral nerve regeneration induction, dissolution enhancement, and non-toxic, biocompatible properties .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-19057
CAS No.: 114914-42-0
Synonyms: MK-467; L-659066
Vatinoxan (MK-467) is an alpha 2-adrenergic receptor antagonist. The peripheral selectivity of Vatinoxan determines that it has limited penetration across the blood-brain barrier and therefore has low concentrations in the central nervous system. Vatinoxan antagonizes alpha 2-adrenergic receptor receptors by binding to them, thereby reducing or preventing cardiovascular effects caused by α2-adrenergic agonists. Vatinoxan can be used in studies of cardiovascular effects, sedation and analgesia .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-19057A
CAS No.: 130466-38-5
Synonyms: MK-467 hydrochloride; L-659066 hydrochloride
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease Endocrinology

Vatinoxan hydrochloride (MK-467 hydrochloride;L-659066 hydrochloride) is a peripheral α2 adrenergic receptor antagonist.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101381
CAS No.: 102394-31-0
Purity:  99.93%
Synonyms: AF-DX 116
Target:  

mAChR

Otenzepad (AF-DX 116) is a selective and competitive M2 muscarinic acetylcholine receptor antagonist, with IC50 values of 640 nM and 386 nM for rabbit peripheral lung and rat heart, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101176
CAS No.: 93515-00-5
Purity:  ≥99.0%
Target:  

Melatonin Receptor

Research Areas:  

Cancer

2-Iodomelatonin is a potent agonist of melatonin receptor 1 (MT1) with a Ki value of 28 pM, it is more 5-fold selective for MT1 over MT2 . 2-iodomelatonin can be used to identify, characterize and localize melatonin binding sites in the brain and peripheral tissues .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-18977
CAS No.: 1380424-42-9
Target:  

MAGL

KML29 is an extremely selective, orally active and irreversible MAGL inhibitor, with IC50 values of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively. KML29 exhibits minimal cross-reactivity toward other central and peripheral serine hydrolases, including no detectable activity against FAAH .
loading...
    loading...